First Time Loading...

Cullinan Oncology Inc
NASDAQ:CGEM

Watchlist Manager
Cullinan Oncology Inc Logo
Cullinan Oncology Inc
NASDAQ:CGEM
Watchlist
Price: 26.72 USD 1.29% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

484.2m
-2%
Assets
Growth Rates:
1 Year
-14%
3 Years
+126%
5 Years
-
7 Years
-
10 Years
-
30.5m
+18%
Liabilities
Growth Rates:
1 Year
+17%
3 Years
+94%
5 Years
-
7 Years
-
10 Years
-
453.7m
-3%
Equity
Growth Rates:
1 Year
-15%
3 Years
+128%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Cullinan Oncology Inc

484.2m
Assets
30.5m
Liabilities
484.2m
Assets
30.5m
Liabilities
Current Assets 480.2m
Cash & Short-Term Investments 467.1m
Other Current Assets 13.1m
Non-Current Assets 4m
PP&E 3.5m
Other Non-Current Assets 459k
Current Liabilities 28.1m
Accounts Payable 2.5m
Accrued Liabilities 25.6m
Non-Current Liabilities 2.3m
Other Non-Current Liabilities 2.3m

Balance Sheet
Cullinan Oncology Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
34
63
168
60
156
98
Cash Equivalents
34
63
168
60
156
98
Short-Term Investments
0
35
42
231
311
369
Other Current Assets
0
2
2
6
7
13
Total Current Assets
34
100
212
297
475
480
PP&E Net
0
0
0
0
5
4
PP&E Gross
0
0
0
0
5
4
Accumulated Depreciation
0
0
0
0
0
0
Long-Term Investments
0
0
0
140
81
0
Other Long-Term Assets
0
0
2
0
1
0
Total Assets
35
N/A
101
+190%
215
+114%
437
+104%
561
+28%
484
-14%
Liabilities
Accounts Payable
0
1
10
3
3
2
Accrued Liabilities
1
2
5
9
15
26
Short-Term Debt
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
4
0
Total Current Liabilities
1
3
14
12
23
28
Long-Term Debt
0
0
0
0
0
0
Minority Interest
0
1
1
0
0
0
Other Liabilities
0
0
0
0
4
2
Total Liabilities
1
N/A
4
+150%
16
+349%
12
-22%
26
+114%
30
+17%
Equity
Common Stock
54
138
277
0
0
0
Retained Earnings
21
42
93
159
48
201
Additional Paid In Capital
0
1
16
585
585
655
Other Equity
0
0
0
1
3
0
Total Equity
33
N/A
97
+191%
199
+105%
425
+114%
535
+26%
454
-15%
Total Liabilities & Equity
35
N/A
101
+190%
215
+114%
437
+104%
561
+28%
484
-14%
Shares Outstanding
Common Shares Outstanding
41
40
41
44
46
43
Preferred Shares Outstanding
0
0
196
0
0
0

See Also

Summary
CGEM intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGEM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGEM stock valuation using valuation multiples.
Wall Street Estimates
CGEM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGEM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.